Vascular mimicry: A potential therapeutic target in breast cancer

Hadi Chavoshi1, Neda Poormolaie2, Vahid Vahedian3

  • 1Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Vascular mimicry (VM) is a key factor in breast cancer treatment failure, independent of angiogenesis. Targeting VM offers a promising therapeutic strategy to overcome treatment resistance and prevent disease recurrence.

Area of Science:

  • Oncology
  • Cancer Biology
  • Medical Research

Background:

  • Invasive breast cancer treatment faces challenges due to invasion and metastasis.
  • Tumor angiogenesis, while targeted, often leads to treatment failure and recurrence.
  • Alternative mechanisms like vascular mimicry (VM) are critical for tumor survival.

Purpose of the Study:

  • To review the formation of vascular mimicry (VM) in breast cancer.
  • To explore the therapeutic potential of targeting VM in breast cancer treatment.

Main Methods:

  • Literature review on vascular mimicry formation in breast cancer.
  • Analysis of existing therapeutic strategies targeting angiogenesis.
  • Evaluation of the role of VM in treatment resistance and recurrence.

Main Results:

  • Vascular mimicry involves cancer cells forming tumor vasculature independently of angiogenesis.
  • VM contributes significantly to nutrient and oxygen supply for tumor cells.
  • Targeting angiogenesis alone is insufficient, highlighting the importance of VM.

Conclusions:

  • Vascular mimicry is a critical mechanism in breast cancer progression and treatment failure.
  • Targeting VM presents a novel therapeutic avenue for invasive breast cancer.
  • Further research into VM inhibition could improve treatment outcomes and reduce recurrence.